Healthcare provider profile · identity verified

Mohammad Tabatabaei, P.A.-C

Physician Assistant · SULLIVAN, IL · NPI 1215954813

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	649	141
Atorvastatin Calcium	Atorvastatin Calcium	587	138
Amlodipine Besylate	Amlodipine Besylate	431	101
Losartan Potassium	Losartan Potassium	386	86
Metformin Hcl	Metformin Hcl	359	84
Gabapentin	Gabapentin	332	63
Lisinopril	Lisinopril	314	84
Hydrochlorothiazide	Hydrochlorothiazide	304	79
Rosuvastatin Calcium	Rosuvastatin Calcium	272	68
Furosemide	Furosemide	237	56
Metoprolol Succinate	Metoprolol Succinate	233	60
Omeprazole	Omeprazole	221	53
Metoprolol Tartrate	Metoprolol Tartrate	220	53
Simvastatin	Simvastatin	218	49
Albuterol Sulfate Hfa	Albuterol Sulfate	211	49
Pantoprazole Sodium	Pantoprazole Sodium	209	53
Pravastatin Sodium	Pravastatin Sodium	202	50
Tamsulosin Hcl	Tamsulosin Hcl	198	49
Montelukast Sodium	Montelukast Sodium	196	46
Eliquis	Apixaban	193	26
Fluoxetine Hcl	Fluoxetine Hcl	188	35
Carvedilol	Carvedilol	185	47
Meloxicam	Meloxicam	175	51
Trulicity	Dulaglutide	169	27
Metformin Hcl Er	Metformin Hcl	159	31
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	150	42
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	150	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	137	24
Potassium Chloride	Potassium Chloride	135	31
Trazodone Hcl	Trazodone Hcl	134	32
Allopurinol	Allopurinol	123	30
Buspirone Hcl	Buspirone Hcl	121	25
Tramadol Hcl	Tramadol Hcl	116	24
Escitalopram Oxalate	Escitalopram Oxalate	110	21
Warfarin Sodium	Warfarin Sodium	106	15
Clopidogrel	Clopidogrel Bisulfate	103	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	102	29
Citalopram Hbr	Citalopram Hydrobromide	90	21
Jardiance	Empagliflozin	90	17
Fluticasone Propionate	Fluticasone Propionate	81	29
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	81	21
Duloxetine Hcl	Duloxetine Hcl	79	21
Sertraline Hcl	Sertraline Hcl	79	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	73	11
Lovastatin	Lovastatin	71	15
Xarelto	Rivaroxaban	71	13
Famotidine	Famotidine	69	18
Ropinirole Hcl	Ropinirole Hcl	64	15
Ezetimibe	Ezetimibe	63	12
Alprazolam	Alprazolam	62	suppressed
Ozempic	Semaglutide	58	11
Atenolol	Atenolol	55	13
Amitriptyline Hcl	Amitriptyline Hcl	54	15
Torsemide	Torsemide	53	suppressed
Finasteride	Finasteride	52	15
Alendronate Sodium	Alendronate Sodium	47	13
Doxycycline Hyclate	Doxycycline Hyclate	47	29
Hydralazine Hcl	Hydralazine Hcl	47	suppressed
Lorazepam	Lorazepam	47	suppressed
Pregabalin	Pregabalin	47	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	46	11
Glipizide	Glipizide	45	11
Methylprednisolone	Methylprednisolone	45	42
Hydroxyzine Hcl	Hydroxyzine Hcl	43	11
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	43	suppressed
Carbamazepine	Carbamazepine	42	suppressed
Celecoxib	Celecoxib	42	suppressed
Divalproex Sodium	Divalproex Sodium	42	suppressed
Mounjaro	Tirzepatide	42	suppressed
Spironolactone	Spironolactone	42	suppressed
Verapamil Er	Verapamil Hcl	42	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	41	30
Bydureon Bcise	Exenatide Microspheres	38	suppressed
Januvia	Sitagliptin Phosphate	35	suppressed
Prednisone	Prednisone	35	25
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	35	suppressed
Tizanidine Hcl	Tizanidine Hcl	34	19
Bupropion Xl	Bupropion Hcl	33	suppressed
Clonazepam	Clonazepam	32	suppressed
Humalog Kwikpen U-100	Insulin Lispro	32	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	suppressed
Olanzapine	Olanzapine	32	suppressed
Clonidine Hcl	Clonidine Hcl	31	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	31	suppressed
Azithromycin	Azithromycin	29	26
Levetiracetam	Levetiracetam	29	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	25	suppressed
Glipizide Er	Glipizide	25	suppressed
Ventolin Hfa	Albuterol Sulfate	25	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Amiodarone Hcl	Amiodarone Hcl	23	suppressed
Fenofibrate	Fenofibrate	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	12
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	21	suppressed
Cephalexin	Cephalexin	21	15
Ulticare Pen Needle	Pen Needle, Diabetic	21	suppressed
Baclofen	Baclofen	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Klor-Con M20	Potassium Chloride	20	suppressed
Betamethasone Valerate	Betamethasone Valerate	19	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Glimepiride	Glimepiride	19	suppressed
Rizatriptan	Rizatriptan Benzoate	19	suppressed
Incruse Ellipta	Umeclidinium Bromide	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	15
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	17	suppressed
Digoxin	Digoxin	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Labetalol Hcl	Labetalol Hcl	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Nystatin	Nystatin	17	11
Tresiba Flextouch U-100	Insulin Degludec	17	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Brilinta	Ticagrelor	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Nabumetone	Nabumetone	16	suppressed
Bevespi Aerosphere	Glycopyrrolate/Formoterol Fum	15	suppressed
Gemtesa	Vibegron	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	12
Amoxicillin	Amoxicillin	14	13
Benazepril Hcl	Benazepril Hcl	14	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Calcitriol	Calcitriol	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	11
Diazepam	Diazepam	14	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Nitroglycerin	Nitroglycerin	14	13
Novolog	Insulin Aspart	14	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	14	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Topiramate	Topiramate	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Ramipril	Ramipril	12	suppressed
Risperidone	Risperidone	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Azathioprine	Azathioprine	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Levofloxacin	Levofloxacin	11	11
Lidocaine	Lidocaine	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Saxagliptin Hcl	Saxagliptin Hcl	11	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	11	suppressed
Victoza 2-Pak	Liraglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error